Quick Answer
Perspective Therapeutics, Inc. reported Operating Income of -$113.56 million for fiscal year 2025.
Perspective Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$113.56M | -25.0% |
| 2024 | -$90.89M | -122.0% |
| 2023 | -$40.94M | -372.1% |
| 2022 | -$8.67M | -35.1% |
| 2022 | -$6.42M | -86.3% |
| 2021 | -$3.45M | +0.9% |
| 2020 | -$3.48M | +33.8% |
| 2019 | -$5.25M | +21.9% |
| 2018 | -$6.73M | -6.7% |
| 2017 | -$6.31M | -24.1% |
| 2016 | -$5.08M | -17.2% |
| 2015 | -$4.34M | +5.5% |
| 2014 | -$4.59M | -12.8% |
| 2013 | -$4.07M | -13.0% |
| 2012 | -$3.60M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.86M | -49.5% | -15.9% |
| June 30, 2025 | -$24.04M | -68.5% | -10.1% |
| March 31, 2025 | -$21.83M | -67.9% | -17.2% |
| September 30, 2024 | -$18.63M | -91.1% | -30.6% |
| June 30, 2024 | -$14.26M | -46.2% | -9.7% |
| March 31, 2024 | -$13.01M | -33.2% | -33.4% |
| September 30, 2023 | -$9.75M | -131.7% | +0.0% |
| June 30, 2023 | -$9.75M | -363.2% | +0.1% |
- Perspective Therapeutics, Inc. showed a decrease of -25.0% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, Perspective Therapeutics, Inc.’s operating income has declined by 3056.3% (from -$3.60 million to -$113.56 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: